OMER - Omeros Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Seattle,
United States
Type: Equity
OMER price evolution
OMER
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.11 | $30.64 | $6.6 | $3.83 |
| Short term investments | $164.74 | $279.67 | $334.68 | $367.53 |
| Net receivables | $8.1 | $6.88 | $11.19 | $10.03 |
| Inventory | ||||
| Total current assets | $217.9 | $351.34 | $388.56 | $417.04 |
| Long term investments | $1.05 | $1.05 | $1.05 | $1.05 |
| Property, plant & equipment | $20.58 | $21.18 | $22.01 | $22.36 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $160.37 | $141.73 | $138.86 | $143.09 |
| Total investments | $165.8 | $280.72 | $335.73 | $368.58 |
| Total assets | $378.27 | $493.07 | $527.42 | $560.13 |
| Current liabilities | ||||
| Accounts payable | $7.71 | $5.87 | $9.55 | $6.45 |
| Deferred revenue | ||||
| Short long term debt | $13.74 | $106.45 | $104.19 | $101.92 |
| Total current liabilities | $53.32 | $147.18 | $143.54 | $139.19 |
| Long term debt | $347.85 | $359.85 | $362.88 | $365.55 |
| Total noncurrent liabilities | $349.94 | $359.85 | $363.37 | $366 |
| Total debt | $361.58 | $466.3 | $467.07 | $467.48 |
| Total liabilities | $403.25 | $507.02 | $506.91 | $505.2 |
| Shareholders' equity | ||||
| Retained earnings | -$753.53 | -$744.46 | -$706.71 | -$669.42 |
| Other shareholder equity | ||||
| Total shareholder equity | -$24.98 | -$13.95 | $20.51 | $54.94 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7.11 | $11.01 | $100.81 | $10.5 |
| Short term investments | $164.74 | $183.91 | $56.46 | $124.45 |
| Net receivables | $8.1 | $242.02 | $38.16 | $3.84 |
| Inventory | $1.35 | |||
| Total current assets | $217.9 | $443.24 | $247.89 | $151.28 |
| Long term investments | $1.05 | $1.05 | $1.05 | $1.05 |
| Property, plant & equipment | $20.58 | $23.25 | $30.01 | $28.08 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $160.37 | $147.73 | $171.38 | $29.76 |
| Total investments | $165.8 | $184.96 | $57.51 | $125.51 |
| Total assets | $378.27 | $590.97 | $419.27 | $181.04 |
| Current liabilities | ||||
| Accounts payable | $7.71 | $5.99 | $13.4 | $4.2 |
| Deferred revenue | ||||
| Short long term debt | $13.74 | $98.69 | $5.25 | $3.78 |
| Total current liabilities | $53.32 | $136.38 | $51.79 | $36.74 |
| Long term debt | $347.85 | $346.49 | $342.58 | $265.06 |
| Total noncurrent liabilities | $349.94 | $368.9 | $343.7 | $265.06 |
| Total debt | $361.58 | $467.15 | $347.84 | $268.84 |
| Total liabilities | $403.25 | $505.29 | $395.49 | $301.79 |
| Shareholders' equity | ||||
| Retained earnings | -$753.53 | -$635.72 | -$683.13 | -$872.67 |
| Other shareholder equity | ||||
| Total shareholder equity | -$24.98 | $85.68 | $23.78 | -$120.75 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $28.89 | $31.73 | $29.64 | $24.61 |
| Selling, general & administrative | $10.88 | $16.42 | $11.26 | $11.1 |
| Total operating expenses | $39.77 | $48.15 | $40.9 | $35.71 |
| Operating income | -$39.77 | -$48.15 | -$40.9 | -$35.71 |
| Income from continuing operations | ||||
| EBIT | -$2 | -$29.83 | -$29.36 | -$25.77 |
| Income tax expense | ||||
| Interest expense | $7.06 | $7.92 | $7.93 | $7.93 |
| Net income | ||||
| Net income | -$9.07 | -$37.75 | -$37.29 | -$33.7 |
| Income (for common shares) | -$9.07 | -$37.75 | -$37.29 | -$33.7 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $73.81 | |||
| Cost of revenue | $0.9 | |||
| Gross Profit | $72.91 | |||
| Operating activities | ||||
| Research & development | $114.87 | $112.72 | $118.78 | $110.82 |
| Selling, general & administrative | $49.66 | $50.67 | $54.84 | $72.69 |
| Total operating expenses | $164.53 | $163.39 | $173.62 | $183.51 |
| Operating income | -$164.53 | -$163.39 | -$173.62 | -$110.6 |
| Income from continuing operations | ||||
| EBIT | -$86.97 | $70.12 | $213.9 | -$123.32 |
| Income tax expense | -$12.01 | |||
| Interest expense | $30.84 | $22.7 | $19.67 | $26.75 |
| Net income | ||||
| Net income | -$117.81 | $47.42 | $194.24 | -$138.06 |
| Income (for common shares) | -$117.81 | $47.42 | $194.24 | -$138.06 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$9.07 | -$37.75 | -$37.29 | -$33.7 |
| Operating activities | ||||
| Depreciation | $0.2 | $0.2 | $0.33 | $0.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.69 | $3.23 | $2.77 | $2.95 |
| Total cash flows from operations | -$34.83 | -$32.65 | -$32.34 | $174.54 |
| Investing activities | ||||
| Capital expenditures | -$0.12 | -$0.03 | -$0.28 | |
| Investments | $116.36 | $57.2 | $35.65 | -$181.33 |
| Total cash flows from investing | $116.24 | $57.17 | $35.38 | -$181.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$4.65 | $0.05 | $0.1 | |
| Net borrowings | -$100.3 | -$0.54 | -$0.36 | -$0.39 |
| Total cash flows from financing | -$104.95 | -$0.48 | -$0.26 | -$0.39 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$23.54 | $24.04 | $2.77 | -$7.18 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$117.81 | $47.42 | $194.24 | -$138.06 |
| Operating activities | ||||
| Depreciation | $0.92 | $0.95 | $1.39 | $1.62 |
| Business acquisitions & disposals | $125.99 | |||
| Stock-based compensation | $11.65 | $14.07 | $17.63 | $14.93 |
| Total cash flows from operations | $74.73 | -$86.48 | -$109.72 | -$100.09 |
| Investing activities | ||||
| Capital expenditures | -$0.43 | -$0.11 | -$0.28 | -$0.28 |
| Investments | $27.88 | -$127.45 | $67.99 | -$66.75 |
| Total cash flows from investing | $27.45 | -$127.56 | $193.71 | -$67.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$4.5 | $0.41 | $8.38 | $98.7 |
| Net borrowings | -$101.58 | $123.83 | -$1.82 | $68.19 |
| Total cash flows from financing | -$106.08 | $124.25 | $6.32 | $174.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.9 | -$89.8 | $90.31 | $7.42 |
News
Fundamentals
| Market cap | $204.17M |
|---|---|
| Enterprise value | $558.65M |
| Shares outstanding | 61.13M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$86.05M |
| EBIT | -$86.97M |
| Net Income | -$117.81M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -1.73 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -6.49 |
| EV/EBIT | -6.42 |
| P/S ratio | N/A |
| P/B ratio | -8.17 |
| Book/Share | -0.41 |
| Cash/Share | 0.12 |
| EPS | -$1.93 |
|---|---|
| ROA | -24.06% |
| ROE | -1.29K% |
| Debt/Equity | -16.14 |
|---|---|
| Net debt/EBITDA | -4.60 |
| Current ratio | 4.09 |
| Quick ratio | 4.09 |